Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Vertex Pharmaceuticals, Inc shares valued at $1,647,810 were sold by ALTSHULER DAVID on Mar 13 ’25. At $510.00 per share, ALTSHULER DAVID sold 3,231 shares. The insider’s holdings dropped to 23,281 shares worth approximately $11.65 million following the completion of this transaction.
Also, ALTSHULER DAVID purchased 3,231 shares, netting a total of over 1,647,810 in proceeds.
Before that, WAGNER CHARLES F JR had sold 3,298 shares from its account. In a trade valued at $1,649,000, the EVP & Chief Financial Officer traded Vertex Pharmaceuticals, Inc shares for $500.00 each. Upon closing the transaction, the insider’s holdings decreased to 3,298 shares, worth approximately $25.85 million.
As published in a research note from Canaccord Genuity on February 12, 2025, Vertex Pharmaceuticals, Inc [VRTX] has been rated up from a Sell to a Hold and the price target has been revised to $424 from $408. Analysts at Canaccord Genuity upgraded the stock from ‘”a Sell”‘ to ‘”a Hold”‘ outlook in a report released in mid February. As of January 30, 2025, Wells Fargo has decreased its “an Overweight” rating to a “an Equal weight” for VRTX. Earlier on December 20, 2024, H.C. Wainwright resumed its rating. Their recommendation was “a Buy” for VRTX stock.
Analyzing VRTX Stock Performance
During the last five days, there has been a drop of approximately -2.39%. Over the course of the year, Vertex Pharmaceuticals, Inc shares have jumped approximately 24.23%. Shares of the company reached a 52-week high of $519.68 on 03/14/25 and a 52-week low of $397.24 on 01/13/25. A 50-day SMA is recorded $472.42, while a 200-day SMA reached $470.09.
Support And Resistance Levels for Vertex Pharmaceuticals, Inc (VRTX)
According to the 24-hour chart, there is a support level at 495.83, which, if violated, would cause prices to drop to 491.37. In the upper region, resistance lies at 506.69. The next price resistance is at 513.09. RSI (Relative Strength Index) is 55.31 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 3.26, which suggests the price will increase in the coming days. Percent R is at 49.24%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
